Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
THE US Food and Drug Administration (FDA) has approved the second drug in a novel class of powerful cholesterol-lowering medications.
The new drug, Repatha, made by Amgen, is intended for people with extremely high cholesterol levels and those with heart disease who cannot...